Rationale: To address the lung donor shortage, we obtained institutional review board and US Food and Drug Administration approval to transplant lungs recovered from uncontrolled donation after circulatory determination of death donors (uDCDDs).
Objectives: To compare outcomes of recipients of lungs recovered from uDCDDs vs. brain-dead donors.